Compare HSDT & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HSDT | BHST |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | Canada |
| Employees | 21 | 87 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.2M | 97.7M |
| IPO Year | N/A | N/A |
| Metric | HSDT | BHST |
|---|---|---|
| Price | $2.17 | $4.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $4.00 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 363.1K | 26.6K |
| Earning Date | 05-04-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $91.56 | $146.27 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.28 | $4.10 |
| 52 Week High | $25.50 | $12.80 |
| Indicator | HSDT | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 53.60 | 59.70 |
| Support Level | $1.71 | $4.27 |
| Resistance Level | $2.37 | $5.02 |
| Average True Range (ATR) | 0.16 | 0.13 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 81.30 | 72.86 |
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.